Rotondo, Cinzia <br/><br/>
No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.  [electronic resource] 

 -  International journal of rheumatic diseases  Jan 2017 
 - 90-96 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1756-185X 
<br/><br/><label>Standard No.: </label>10.1111/1756-185X.12721  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antihypertensive Agents--therapeutic use<br/>Biomarkers--blood<br/>Blood Pressure--drug effects<br/>Bosentan<br/>Endothelin Receptor Antagonists--therapeutic use<br/>Exercise Tolerance--drug effects<br/>Female<br/>Humans<br/>Hypertension, Pulmonary--blood<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Natriuretic Peptide, Brain--blood<br/>Peptide Fragments--blood<br/>Prospective Studies<br/>Recovery of Function<br/>Scleroderma, Systemic--complications<br/>Sulfonamides--therapeutic use<br/>Time Factors<br/>Treatment Outcome<br/>Up-Regulation